Killing Cancer With a Virus 662
just___giver writes "The U.S. National Cancer Institute has just decided to fund multiple human clinical studies to test the reovirus. This naturally occuring virus has a remarkable ability to infect and kill cancer cells, without affecting normal, healthy cells. Here is a before and after picture of a terminal patient with an actively growing neck tumour that had failed to respond to conventional treatments. This tumour was eliminated with only a single injection of the Reovirus. Researchers at Oncolytics Biotech have shown that the Reovirus can kill many types of cancer, including breast, prostate, pancreatic and brain tumours. Human clinical trial results indicate that there are no safety concerns and that the reovirus shrinks and even eliminates tumours injected with this virus. Numerous other third party studies show that the reovirus should be an important discovery in the treatment of 2/3 of all human cancers."
good... (Score:4, Informative)
i find these as very very welcome news, especially so that i have personally seen the effects of conventional therapies; if you're lucky you'll have a tumor they can cut out, if not then too many of those chemotherapies are way too toxic, and quite a few radiotherapies too.
Clarify (Score:5, Informative)
Hope this clarifies things.
Re:How do they know? (Score:1, Informative)
Re:good... (Score:4, Informative)
Inhibition of tumor angiogenesis by cannabinoids.
Blazquez C, Casanova ML, Planas A, Del Pulgar TG, Villanueva C, Fernandez-Acenero MJ, Aragones J, Huffman JW, Jorcano JL, Guzman M.
Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Madrid, Spain.
Cannabinoids, the active components of marijuana and their derivatives, induce tumor regression in rodents (8). However, the mechanism of cannabinoid antitumoral action in vivo is as yet unknown. Here we show that local administration of a nonpsychoactive cannabinoid to mice inhibits angiogenesis of malignant gliomas as determined by immunohistochemical analyses and vascular permeability assays. In vitro and in vivo experiments show that at least two mechanisms may be involved in this cannabinoid action: the direct inhibition of vascular endothelial cell migration and survival as well as the decrease of the expression of proangiogenic factors (vascular endothelial growth factor and angiopoietin-2) and matrix metalloproteinase-2 in the tumors. Inhibition of tumor angiogenesis may allow new strategies for the design of cannabinoid-based antitumoral therapies.
PMID: 12514108 [PubMed - indexed for MEDLINE]
Re:Resistance (Score:4, Informative)
I may be out of date in my medical knowledge... but I'm pretty sure cancers can only develop an immunity in a single person over a course of treatment, and can't spread like a virus or bacteria to other people carrying the acquired immunity with it.
After all, cancers aren't transmitted between people, they spontaneously appear for a variety of reasons.
Re:How do they know? (Score:3, Informative)
In addition, if the virus only responds to the receptors found on cancer cells (which is, I imagine, how it works), then there is next to no chance of it ever infecting normal healthy cells.
Though, I agree...this should be studied for a couple of more years, just to be on the safe side. However, I'm nigh positive that this could lead to a definitive cancer cure.
Re:How do they know? (Score:4, Informative)
That text comes from section 3 of this [uwaterloo.ca] article. So it would seem that the answer to your question was determined quite some time ago.
Re:But... (Score:5, Informative)
However, it appears that the virus itself is fairly effective at killing of tumor cells on it's own which is fairly interesting. As it's not associated with any pathogenesis this is definately an interesting step.
Yes you can get infected more than once, hell you can get reinfected over and over again. If you have antibodies it'll probably be a fairly asymptomatic infection (pardon my spelling).
Geneticly Modifed Virus ... (Score:1, Informative)
"its proprietary formulation of the human reovirus".
Re:Not so fast buckwheat! (Score:3, Informative)
that's why they have (Score:5, Informative)
They've been using this in HIV patients for years. The only reason I could see them being more hesitant to treat cancer patients in a like manner is this: there ARE treatments for cancer that are curative... most all the treatments for HIV simply buy time... they do not eliminate the disease. Chemo is extraordinarily unpleasant, but it does have a proven track record...
Re:Okay, lets try it then... (Score:2, Informative)
Re:How do they know? (Score:5, Informative)
Re:How do they know? (Score:5, Informative)
Actually, the FAQ linked to by the article has a very simple description of how it works:
So in fact, it can and does infect normal cells; but it's so weak that it never causes any problem. Elsewhere on the FAQ it says that most humans show evidence of having been infected by it at some time (it's a naturally occuring virus).
Re:How do they know? (Score:5, Informative)
Re:Surgical strike medicine (Score:1, Informative)
Radiation on the other hand is far MORE of a surgical strike approach. The radiate just the tumor area, not the entire body.
Re:Calgary builds Cure for Cancer (Score:0, Informative)
Re:Okay, lets try it then... (Score:2, Informative)
You're obviously not familiar with the law, at all.
There are very clear doctrines in many states regarding Assumption of Risk. So long as the doctor makes it very clear to the patient that the cure is only possible, and it there might be outrageous side-effects anyway, the doc should be fine.
Unless, of course, the doc lied / misrepresented facts to get a new treatment tested--in which case, the doc should pay.
Re:old soviet PHAGE technique (Score:2, Informative)
This startup is using a naturally-occuring virus to kill cells with compromised anti-virus defenses. It just so happens that many cancer cells are so compromised.
Neat work! But definitely not the same.
--Anil
Slashdot editors: still asleep at the wheel. (Score:5, Informative)
Re:Okay, lets try it then... (Score:4, Informative)
Even the thought of having to defend against such a suit may well be enough to stop a lot of places from doing this. Such a waste.
Re:good... (Score:5, Informative)
The treatment sucks, but it's better than dying!
Re:Okay, lets try it then... (Score:5, Informative)
Speaking personally, I just underwent surgery and am awaiting radiation for a tumor. I would have much prefer to have gotten an injection, a severe cold, no tumor, and the continued use of an important body part. But I was not selected for such a study and couldn't have paid for the drug anyway. Such is life. I am just glad that my prognosis is good and hope that the virus will be approved as soon as is scientifically appropriate.
Re:Surgical strike medicine (Score:3, Informative)
And you don't infect the entire patient if you can get at the tumor:
Re:Slashdot editors: still asleep at the wheel. (Score:5, Informative)
You hit that one on the head... It's a company PR release no less. Interesting, but definitely astroturf.
From the ONCY Yahoo Stock message board [yahoo.com]...
Re:Slashdot editors: still asleep at the wheel. (Score:3, Informative)
-Todd
Re:Okay, lets try it then... (Score:1, Informative)
Re:Okay, lets try it then... (Score:3, Informative)
Here's some interesting reading: OverLawyered.com [overlawyered.com]
It's not just Reovirus: (Score:3, Informative)
It's shameful that the companies who make the most press releases get the most attention.
Astroturfing is right (Score:1, Informative)
As Doktor Memory said, the post contains no links to substantive biology articles, no discussion of the long and checkered history of attacks on the Ras pathway, and little information about what is actually going on. If you want real information go look at the PubMed on 'reovirus ras' [nih.gov].
It'll be great if reovirus increases survival rates in Ras cancers, but it will not be a magic bullet and it could easily fail final clinical trials for one reason or another. It just ain't over 'til it's over in the pharmaceutical industry.
Re:Physician perspective (Score:3, Informative)
It's only Phase II, not ready for prime time (Score:5, Informative)
On the Oncolytics web site, they only list Phase I and Phase II trials. That's just to evaluate safety and dosing. In Phase III, they finally get around to testing for effectiveness, and they haven't done that yet.
I've seen lots of drugs that did this well in Phase II trials but flunked Phase III. I remember seeing Fortune magazine with the headline on the cover, "Cure for Cancer!" 20 years ago. Unfortunately not. (They got over-enthusiastic about cancer vaccines.)
Phase III is a randomized controlled trial. They randomly assign half the patients to the drug, and half the patients to a placebo. If it really works, you should see the difference. A lot of times it doesn't work and you know the drug is useless. Until the RCT you don't know anything for sure.
Another distinction you have to make is the end point. It's one thing to shrink a tumor, but the main thing most cancer patients are interested in is whether they're going to die. There are a lot of drugs that shrink tumors, but have no effect on how long they live.
Here's a discussion, "Levels of Clinical Evidence in the Primary Literature" [uic.edu]which describes the different levels of evidence. Or look at BMJ [bmj.com] Or if you want to search Google look for "Evidence-based medicine."
I hope this will encourage investors to throw lots of money at basic research and give us a better understanding of why cells become cancerous. It makes the New England Journal of Medicine more fun to read. Who knows? Maybe they'll come up with something useful some day. But not today.
Avg Life expectancy (Score:3, Informative)